Attrition in the context of cancer research refers to the loss of participants during a clinical trial or long-term study. This can occur for various reasons, including adverse side effects, lack of efficacy, personal reasons, or even mortality. High attrition rates can significantly impact the validity and reliability of study outcomes.
